Literature DB >> 22085877

Systemic treatment with the enteric bacterial fermentation product, propionic acid, produces both conditioned taste avoidance and conditioned place avoidance in rats.

Klaus-Peter Ossenkopp1, Kelly A Foley, James Gibson, Melissa A Fudge, Martin Kavaliers, Donald P Cain, Derrick F Macfabe.   

Abstract

Propionic acid, an enteric bacterial fermentation product, has received recent attention in regards to satiety and obesity in humans. The possibility that propionic acid might produce internal aversive cues was investigated in two experiments using conditioned taste avoidance and place avoidance procedures to index the potential aversive nature of systemic treatment with propionic acid in male rats. Experiment 1 examined the effect of systemic treatment with propionic acid (500 mg/kg), LiCl (95 mg/kg) or vehicle (all corrected to pH 7.5) on the formation of conditioned taste avoidance using a lickometer procedure. On 3 acquisition days three groups of rats were injected with propionic acid, LiCl or vehicle, following 30 min access to 0.3M sucrose solution. Both the Propionic acid group and the LiCl group evidenced a conditioned taste avoidance by the end of the acquisition period. During a drug free extinction phase the Propionic acid group showed extinction of the taste avoidance whereas the LiCl group did not. Experiment 2 involved place preference conditioning with propionic acid treatment associated with one novel context and vehicle with a different novel context on 6 conditioning trials for each type of injection. Place avoidance was assessed on two drug free extinction trials. Multi-variable assessment of the unconditioned (Acquisition Trials) and conditioned effects (Extinction Trials) of propionic acid on locomotor activity was quantified as was chamber choice time on the extinction trials. Propionic acid induced a significant place avoidance and significantly reduced locomotor activity on some acquisition trials. During the extinction trials rats exhibited enhanced locomotor activity levels in the propionic acid associated chamber, likely due to the conditioned aversive nature of this chamber.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085877     DOI: 10.1016/j.bbr.2011.10.045

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  24 in total

1.  Autism spectrum disorder in a child with propionic acidemia.

Authors:  M Al-Owain; N Kaya; H Al-Shamrani; A Al-Bakheet; A Qari; S Al-Muaigl; M Ghaziuddin
Journal:  JIMD Rep       Date:  2012-03-31

2.  Impaired Spatial Cognition in Adult Rats Treated with Multiple Intracerebroventricular (ICV) Infusions of the Enteric Bacterial Metabolite, Propionic Acid, and Return to Baseline After 1 Week of No Treatment: Contribution to a Rodent Model of ASD.

Authors:  Jennifer R Mepham; Francis H Boon; Kelly A Foley; Donald P Cain; Derrick F MacFabe; Klaus-Peter Ossenkopp
Journal:  Neurotox Res       Date:  2019-03-08       Impact factor: 3.911

3.  Etiology of autistic features: the persisting neurotoxic effects of propionic acid.

Authors:  Afaf K El-Ansary; Abir Ben Bacha; Malak Kotb
Journal:  J Neuroinflammation       Date:  2012-04-24       Impact factor: 8.322

4.  Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders.

Authors:  Derrick F MacFabe
Journal:  Microb Ecol Health Dis       Date:  2015-05-29

5.  Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.

Authors:  Richard E Frye; Shannon Rose; John Slattery; Derrick F MacFabe
Journal:  Microb Ecol Health Dis       Date:  2015-05-07

6.  GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet, February 2nd 2015.

Authors: 
Journal:  Microb Ecol Health Dis       Date:  2015-05-29

7.  Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders.

Authors:  Derrick F Macfabe
Journal:  Microb Ecol Health Dis       Date:  2012-08-24

8.  Autism: metabolism, mitochondria, and the microbiome.

Authors:  Derrick Macfabe
Journal:  Glob Adv Health Med       Date:  2013-11

9.  Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner.

Authors:  Kelly A Foley; Klaus-Peter Ossenkopp; Martin Kavaliers; Derrick F Macfabe
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells--possible relevance to autism spectrum disorders.

Authors:  Bistra B Nankova; Raj Agarwal; Derrick F MacFabe; Edmund F La Gamma
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.